title: Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins--significance for the patient.
authors.affiliation: Institute of Inorganic Chemistry - Bioinorganic, Environmental and Radiochemistry, University of Vienna, Austria.
authors.forename: C G
authors.initials: CG
authors.lastname: Hartinger
authors.forename: S
authors.initials: S
authors.lastname: Hann
authors.forename: G
authors.initials: G
authors.lastname: Koellensperger
authors.forename: M
authors.initials: M
authors.lastname: Sulyok
authors.forename: M
authors.initials: M
authors.lastname: Groessl
authors.forename: A R
authors.initials: AR
authors.lastname: Timerbaev
authors.forename: A V
authors.initials: AV
authors.lastname: Rudnev
authors.forename: G
authors.initials: G
authors.lastname: Stingeder
authors.forename: B K
authors.initials: BK
authors.lastname: Keppler
mesh_terms: D000418:Albumins / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D019075:Electrophoresis, Capillary; D006801:Humans; D007191:Indazoles / Q000378:metabolism*; D009369:Neoplasms / Q000097:blood / Q000378:metabolism*; D009942:Organometallic Compounds; D011485:Protein Binding; D012428:Ruthenium; D017975:Ruthenium Compounds / Q000378:metabolism*; D021241:Spectrometry, Mass, Electrospray Ionization; D014168:Transferrin / Q000378:metabolism*
chemical_list: D000418:Albumins; D000970:Antineoplastic Agents; D007191:Indazoles; D009942:Organometallic Compounds; D017975:Ruthenium Compounds; D014168:Transferrin; C499292:indazolium trans-(tetrachlorobis(1H-indazole)ruthenate (III)); D012428:Ruthenium